Centessa Pharmaceuticals plc (CNTA) Tops Q1 EPS by 4c

Centessa Pharmaceuticals plc (NASDAQ: CNTA) reported Q1 EPS of ($0.38), $0.04 better than the analyst estimate of ($0.42).

For earnings history and earnings-related data on Centessa Pharmaceuticals plc (CNTA) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• AXT appoints Tracy Liu to its board of directors
• Goldman reinstates Estee Lauder rating, sees turnaround driving growth and margins